If you’re an adult over age 50 receiving chemotherapy for cancer, you can now take steps to cut your risk for shingles, a painful infection caused by the same virus as the chicken pox.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Preventative options were once limited because the original shingles vaccine, called Zostavax®, was not an option for anyone with a compromised immune system. But the newly approved Shingrix® vaccine is an option.
Unlike the older vaccine, Shingrix is not made from a live virus. “This means there’s no chance you can get shingles from the vaccine,” says clinical immunologist Leonard Calabrese, DO.
Shingrix is administered by two injections, and there is a slight risk of side effects with each.
Some people may experience soreness at the injection site or about 10% of people can have flu-like symptoms, such as muscle aches, fever, chills and fatigue, that can last about a week. However, getting more than 90% protection from shingles over three or more years is a worthwhile trade-off, Dr. Calabrese says.
Oncologist Dale Shepard, MD, PhD, says it’s important if you’re receiving cancer treatment to get the vaccine, if possible.
“Having decreased immunity can increase the likelihood of getting shingles, so that’s even more reason people should maintain their vaccines,” he says.
You should avoid getting Shingrix if you:
If you think you’re a candidate for Shingrix, talk with your doctor about if and when you should receive it. They can explain its benefits and offer advice based on your personal health history.